Igor Jovanović

1.1k total citations · 2 hit papers
21 papers, 590 citations indexed

About

Igor Jovanović is a scholar working on Surgery, Epidemiology and Genetics. According to data from OpenAlex, Igor Jovanović has authored 21 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 6 papers in Epidemiology and 6 papers in Genetics. Recurrent topics in Igor Jovanović's work include Inflammatory Bowel Disease (6 papers), Liver Disease Diagnosis and Treatment (4 papers) and Eosinophilic Esophagitis (3 papers). Igor Jovanović is often cited by papers focused on Inflammatory Bowel Disease (6 papers), Liver Disease Diagnosis and Treatment (4 papers) and Eosinophilic Esophagitis (3 papers). Igor Jovanović collaborates with scholars based in Serbia, United States and Italy. Igor Jovanović's co-authors include Subrata Ghosh, Silvio Danese, Lorna Charles, Keith Usiskin, Jean–Frédéric Colombel, Loren Laine, Denesh K. Chitkara, Ji Hwan Lee, Geert D’Haens and Douglas C. Wolf and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and International Journal of Molecular Sciences.

In The Last Decade

Igor Jovanović

18 papers receiving 574 citations

Hit Papers

Ozanimod as Induction and Maintenance Therapy for Ulcerat... 2021 2026 2022 2024 2021 2023 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Igor Jovanović Serbia 8 277 267 131 93 90 21 590
Siro Bagnoli Italy 17 312 1.1× 389 1.5× 99 0.8× 153 1.6× 196 2.2× 37 788
Pablo León United States 13 198 0.7× 78 0.3× 127 1.0× 78 0.8× 77 0.9× 21 620
Sara De Iudicibus Italy 15 85 0.3× 120 0.4× 203 1.5× 101 1.1× 72 0.8× 29 589
Noritoshi Koh Japan 9 123 0.4× 280 1.0× 223 1.7× 34 0.4× 70 0.8× 14 803
Willem J. de Villiers United States 10 173 0.6× 199 0.7× 146 1.1× 184 2.0× 330 3.7× 20 719
Mitsue Sogawa Japan 16 171 0.6× 142 0.5× 114 0.9× 131 1.4× 333 3.7× 43 747
Andrew Y. F. Li Yim Netherlands 11 65 0.2× 172 0.6× 168 1.3× 101 1.1× 76 0.8× 27 544
İbrahim Hatemı Türkiye 15 286 1.0× 61 0.2× 63 0.5× 39 0.4× 141 1.6× 78 720
P. B. B. Jones New Zealand 14 64 0.2× 163 0.6× 174 1.3× 159 1.7× 99 1.1× 21 724
Christian J. Steib Germany 17 368 1.3× 121 0.5× 174 1.3× 165 1.8× 222 2.5× 43 869

Countries citing papers authored by Igor Jovanović

Since Specialization
Citations

This map shows the geographic impact of Igor Jovanović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Jovanović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Jovanović more than expected).

Fields of papers citing papers by Igor Jovanović

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igor Jovanović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Jovanović. The network helps show where Igor Jovanović may publish in the future.

Co-authorship network of co-authors of Igor Jovanović

This figure shows the co-authorship network connecting the top 25 collaborators of Igor Jovanović. A scholar is included among the top collaborators of Igor Jovanović based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igor Jovanović. Igor Jovanović is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jovanović, Igor, Marija Zdravković, Zoran Todorović, et al.. (2023). Alcohol, Inflammation, and Microbiota in Alcoholic Liver Disease. International Journal of Molecular Sciences. 24(4). 3735–3735. 82 indexed citations breakdown →
2.
Siegmund, Britta, Silvio Danese, J.F. Colombel, et al.. (2022). Long-term use of ozanimod in patients with moderately to severely active ulcerative colitis. Zeitschrift für Gastroenterologie. 60(8). e428–e428. 2 indexed citations
4.
Danese, Silvio, Jean‐Frédéric Colombel, Terry Ponich, et al.. (2022). DOP44 Long-term use of ozanimod in patients with moderately to severely active Ulcerative Colitis. Journal of Crohn s and Colitis. 16(Supplement_1). i093–i094. 4 indexed citations
5.
Wolf, Douglas C., Jean Frédéric Colombel, Terry Ponich, et al.. (2022). Tu1458: LONG-TERM USE OF OZANIMOD IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS. Gastroenterology. 162(7). S–969. 3 indexed citations
6.
Jovanović, Igor, Marija Zdravković, Višeslav Popadić, et al.. (2022). Aging of Liver in Its Different Diseases. International Journal of Molecular Sciences. 23(21). 13085–13085. 32 indexed citations
7.
Branković, Marija, et al.. (2022). Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis. International Journal of Molecular Sciences. 23(9). 5146–5146. 42 indexed citations
8.
9.
Milićević, Ognjen, Igor Jovanović, Marija Zdravković, et al.. (2022). Elevated Transaminases as Predictors of COVID-19 Pneumonia Severity. Medicina. 58(7). 842–842. 6 indexed citations
10.
Branković, Marija, et al.. (2021). The Administration of Tocilizumab to a COVID-19 Patient with Psoriasis Vulgaris – A Case Report. 5(1).
11.
Jovanović, Igor, et al.. (2021). The Role of Ultrasonography in the Diagnosis of Functional Dyspepsia. 25(1). 27–32.
12.
Sandborn, William J., Brian G. Feagan, Geert D’Haens, et al.. (2021). Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis. New England Journal of Medicine. 385(14). 1280–1291. 335 indexed citations breakdown →
13.
Jovanović, Igor, et al.. (2020). P025 Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Induction in the Phase 3 True North Study. The American Journal of Gastroenterology. 115(1). S6–S7. 14 indexed citations
14.
Danese, Silvio, et al.. (2020). P030 Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Maintenance in the Phase 3 True North Study. The American Journal of Gastroenterology. 115(1). S8–S8. 7 indexed citations
15.
Andrejević, Sladjana, et al.. (2017). Triple IgE-positivity to hornet, wasp and bee venom in the patient with anaphylaxis: Diagnostic and therapeutic approach. Vojnosanitetski pregled. 76(8). 839–842. 1 indexed citations
16.
Jovanović, Igor, et al.. (2015). Anismus as a cause of functional constipation: Experience from Serbia. Vojnosanitetski pregled. 72(1). 9–11. 2 indexed citations
17.
Jovanović, Igor, et al.. (2013). Achalasia - two types in the same patient: Case report. Srpski arhiv za celokupno lekarstvo. 141(11-12). 807–809.
18.
Djulejić, Vuk, Slobodan Marinković, Aleksandar Maliković, et al.. (2012). Morphometric analysis, region of supply and microanatomy of the lenticulostriate arteries and their clinical significance. Journal of Clinical Neuroscience. 19(10). 1416–1421. 37 indexed citations
19.
Randjelović, Tomislav, et al.. (2011). Nutritional Insight into Preduodenal Pouch Reconstruction One Year after Total Gastrectomy. Journal of Surgical Research. 176(1). 34–41. 2 indexed citations
20.
Jovanović, Igor, et al.. (2011). Primitive trigeminal artery associated with aterovenous malformation of cerebellum. Vojnosanitetski pregled. 68(8). 699–704. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026